2021-000708-39
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy
Rheinische Friedrich-Wilhelms-Universität Bonn·EU Clinical Trials Register
Study focus
- Disease/Condition
- Glioblastoma
Sponsor & location
- Primary sponsor
- Rheinische Friedrich-Wilhelms-Universität Bonn
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Malignant neoplasm of brainMalignant neoplasm: Brain, unspecifiedMesotheliomaMalignant neoplasm: Brain stemMalignant neoplasm: Overlapping lesion of brain
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2021-000708-39
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2021-000708-39 through Pure Global AI's free database. This phase not specified trial is sponsored by Rheinische Friedrich-Wilhelms-Universität Bonn and is currently status unknown. The study focuses on Glioblastoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.